149 related articles for article (PubMed ID: 24094263)
1. Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs.
Hess RS; Drobatz KJ
J Am Vet Med Assoc; 2013 Oct; 243(8):1154-61. PubMed ID: 24094263
[TBL] [Abstract][Full Text] [Related]
2. Use of insulin glargine in dogs with diabetes mellitus.
Fracassi F; Boretti FS; Sieber-Ruckstuhl NS; Reusch CE
Vet Rec; 2012 Jan; 170(2):52. PubMed ID: 22008227
[TBL] [Abstract][Full Text] [Related]
3. Effect of dietary insoluble fiber on control of glycemia in dogs with naturally acquired diabetes mellitus.
Nelson RW; Duesberg CA; Ford SL; Feldman EC; Davenport DJ; Kiernan C; Neal L
J Am Vet Med Assoc; 1998 Feb; 212(3):380-6. PubMed ID: 9470048
[TBL] [Abstract][Full Text] [Related]
4. An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus.
Palm CA; Boston RC; Refsal KR; Hess RS
J Vet Intern Med; 2009; 23(1):50-5. PubMed ID: 19175720
[TBL] [Abstract][Full Text] [Related]
5. Effect of insulin dosage on glycemic response in dogs with diabetes mellitus: 221 cases (1993-1998).
Hess RS; Ward CR
J Am Vet Med Assoc; 2000 Jan; 216(2):217-21. PubMed ID: 10649757
[TBL] [Abstract][Full Text] [Related]
6. Use of glargine and lente insulins in cats with diabetes mellitus.
Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
[TBL] [Abstract][Full Text] [Related]
7. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
Ashwell SG; Gebbie J; Home PD
Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
[TBL] [Abstract][Full Text] [Related]
8. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of twice-daily, low-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism.
Vaughan MA; Feldman EC; Hoar BR; Nelson RW
J Am Vet Med Assoc; 2008 May; 232(9):1321-8. PubMed ID: 18447776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
12. Effects of insoluble and soluble dietary fiber on glycemic control in dogs with naturally occurring insulin-dependent diabetes mellitus.
Kimmel SE; Michel KE; Hess RS; Ward CR
J Am Vet Med Assoc; 2000 Apr; 216(7):1076-81. PubMed ID: 10754666
[TBL] [Abstract][Full Text] [Related]
13. Treatment of diabetic ketoacidosis in dogs by continuous low-dose intravenous infusion of insulin.
Macintire DK
J Am Vet Med Assoc; 1993 Apr; 202(8):1266-72. PubMed ID: 8496083
[TBL] [Abstract][Full Text] [Related]
14. Insulin glargine has a long duration of effect following administration either once daily or twice daily in divided doses in healthy cats.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2008 Oct; 10(5):488-94. PubMed ID: 18703367
[TBL] [Abstract][Full Text] [Related]
15. Insulin-induced hyperglycemia in diabetic dogs.
Feldman EC; Nelson RW
J Am Vet Med Assoc; 1982 Jun; 180(12):1432-7. PubMed ID: 7047478
[TBL] [Abstract][Full Text] [Related]
16. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
[TBL] [Abstract][Full Text] [Related]
17. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
Nelson RW; Henley K; Cole C;
J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
[TBL] [Abstract][Full Text] [Related]
18. Insulin therapy in cats with diabetes mellitus.
Moise NS; Reimers TJ
J Am Vet Med Assoc; 1983 Jan; 182(2):158-64. PubMed ID: 6298164
[TBL] [Abstract][Full Text] [Related]
19. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus.
Maggiore AD; Nelson RW; Dennis J; Johnson E; Kass PH
J Vet Intern Med; 2012; 26(1):109-15. PubMed ID: 22211582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
